JP7090780B2 - Ｃｄ３に結合する抗体 - Google Patents

Ｃｄ３に結合する抗体 Download PDF

Info

Publication number
JP7090780B2
JP7090780B2 JP2021126403A JP2021126403A JP7090780B2 JP 7090780 B2 JP7090780 B2 JP 7090780B2 JP 2021126403 A JP2021126403 A JP 2021126403A JP 2021126403 A JP2021126403 A JP 2021126403A JP 7090780 B2 JP7090780 B2 JP 7090780B2
Authority
JP
Japan
Prior art keywords
domain
antigen
fab
antibody
binding domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021126403A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021182927A (ja
Inventor
アン フライモサー－グルントショーバー，
トーマス ホーファー，
ラルフ ホッセ，
エッケハルト メスナー，
バレリア ヘ． ニコリーニ，
パブロ ウマーニャ，
イニヤ ヴァルトハウアー，
ウォルフガング リヒター，
アレクサンダー クナウプ，
ハリーナ トロシャノフスカ，
Original Assignee
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2021534306A external-priority patent/JP7061733B2/ja
Application filed by エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト filed Critical エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト
Publication of JP2021182927A publication Critical patent/JP2021182927A/ja
Application granted granted Critical
Publication of JP7090780B2 publication Critical patent/JP7090780B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
JP2021126403A 2018-12-21 2021-08-02 Ｃｄ３に結合する抗体 Active JP7090780B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18214994.8 2018-12-21
EP18214994 2018-12-21
JP2021534306A JP7061733B2 (ja) 2018-12-21 2019-12-19 Ｃｄ３に結合する抗体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021534306A Division JP7061733B2 (ja) 2018-12-21 2019-12-19 Ｃｄ３に結合する抗体

Publications (2)

Publication Number Publication Date
JP2021182927A JP2021182927A (ja) 2021-12-02
JP7090780B2 true JP7090780B2 (ja) 2022-06-24

Family

ID=78819196

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021126403A Active JP7090780B2 (ja) 2018-12-21 2021-08-02 Ｃｄ３に結合する抗体
JP2021153771A Active JP7653881B2 (ja) 2018-12-21 2021-09-22 Ｃｄ３に結合する抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021153771A Active JP7653881B2 (ja) 2018-12-21 2021-09-22 Ｃｄ３に結合する抗体

Country Status (1)

Country Link
JP (2) JP7090780B2 (enrdf_load_stackoverflow)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017525690A (ja) 2014-08-04 2017-09-07 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 二重特異性ｔ細胞活性化抗原結合分子
WO2018060301A1 (en) 2016-09-30 2018-04-05 F. Hoffmann-La Roche Ag Bispecific antibodies against cd3
JP2018524997A (ja) 2015-07-31 2018-09-06 アムゲン リサーチ （ミュンヘン） ゲーエムベーハーＡＭＧＥＮ Ｒｅｓｅａｒｃｈ（Ｍｕｎｉｃｈ）ＧｍｂＨ Ｅｇｆｒｖｉｉｉ及びｃｄ３に結合する二重特異性抗体構築物
JP2018533930A (ja) 2015-10-02 2018-11-22 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 二重特異性ｔ細胞活性化抗原結合分子

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201190132A1 (ru) 2009-02-23 2013-01-30 Гленмарк Фармасьютикалс С.А. Гуманизированные антитела, связывающиеся с cd19, и их применение
WO2014028748A1 (en) 2012-08-15 2014-02-20 Irm Llc Interleukin 2 antibodies and antibody complexes
CA2891493C (en) 2013-02-26 2022-03-15 Roche Glycart Ag Bispecific t cell activating antigen binding molecules
CN107074955B (zh) 2014-11-20 2021-06-22 豪夫迈·罗氏有限公司 针对FolR1和CD3的T细胞活化性双特异性抗原结合分子

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017525690A (ja) 2014-08-04 2017-09-07 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 二重特異性ｔ細胞活性化抗原結合分子
JP2018524997A (ja) 2015-07-31 2018-09-06 アムゲン リサーチ （ミュンヘン） ゲーエムベーハーＡＭＧＥＮ Ｒｅｓｅａｒｃｈ（Ｍｕｎｉｃｈ）ＧｍｂＨ Ｅｇｆｒｖｉｉｉ及びｃｄ３に結合する二重特異性抗体構築物
JP2018533930A (ja) 2015-10-02 2018-11-22 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 二重特異性ｔ細胞活性化抗原結合分子
WO2018060301A1 (en) 2016-09-30 2018-04-05 F. Hoffmann-La Roche Ag Bispecific antibodies against cd3

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PLOS ONE，2014年，Vol.9, No.6，e100736, pp.1-13

Also Published As

Publication number Publication date
JP7653881B2 (ja) 2025-03-31
JP2022028645A (ja) 2022-02-16
JP2021182927A (ja) 2021-12-02

Similar Documents

Publication Publication Date Title
JP7061733B2 (ja) Ｃｄ３に結合する抗体
JP7586889B2 (ja) Ｎｋｇ２ｄに結合する抗体
US20210230278A1 (en) Antibodies binding to HLA-A2/MAGE-A4
US20220041747A1 (en) Antibodies binding to steap-1
US20230416411A1 (en) Antibodies binding to cd3 and folr1
KR20230025665A (ko) Cd3에 결합하는 항체
JP2025503399A (ja) Ｃｄ３及びｐｌａｐに結合する抗体
JP7090780B2 (ja) Ｃｄ３に結合する抗体
RU2810924C2 (ru) Антитела, связывающиеся с cd3
RU2832669C2 (ru) Антитела, связывающиеся с cd3
TW202519549A (zh) 與 cd3 結合之抗體

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210811

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210811

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20210811

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220315

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220523

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220607

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220614

R150 Certificate of patent or registration of utility model

Ref document number: 7090780

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250